SFMG Wealth Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

SFMG Wealth Advisors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,994	Closed	-$55K	–	165
2019 Q1	$55K	Hold	11,994	–	–	0.01%	143
2018 Q4	$42K	Hold	11,994	–	–	0.01%	135
2018 Q3	$107K	Hold	11,994	–	–	0.02%	139
2018 Q2	$87K	Hold	11,994	–	–	0.01%	149
2018 Q1	$72K	Hold	11,994	–	–	0.01%	148
2017 Q4	$115K	Buy	+11,994	New	+$78.5K	0.02%	140

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

SFMG Wealth Advisors's INSY Position: Q2 2019 in Review

SFMG Wealth Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 11,994 shares — an estimated $55K sold.

SFMG Wealth Advisors first reported a position in INSY in Q4 2017 and held it in 6 quarters. The position peaked at $115K in Q4 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

SFMG Wealth Advisors reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
SFMG Wealth Advisors sold 11,994 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $55K.
SFMG Wealth Advisors first reported a position in Insys Therapeutics, Inc. in Q4 2017 and held it in 6 quarters.
SFMG Wealth Advisors's Insys Therapeutics, Inc. position peaked at $115K in Q4 2017.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on SFMG Wealth Advisors's 13F filing for Q2 2019, filed 5 Aug 2019.